» Authors » Claudia Klein

Claudia Klein

Explore the profile of Claudia Klein including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 52
Citations 453
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pezeshkpoor B, Sereda N, Becker-Gotot J, Berkemeier A, Matuschek I, Muller J, et al.
J Thromb Haemost . 2024 Oct; 23(1):85-96. PMID: 39401737
Background: Acquired hemophilia A (AHA) is a rare and severe bleeding disorder characterized by autoantibodies inhibiting coagulation factor (F)VIII. Current treatment of AHA involves bypassing agents or FVIII replacement therapy,...
2.
Muller J, Albert T, Klein C, Horneff S, Ruhl H, Potzsch B, et al.
Haemophilia . 2024 Aug; 30(5):1203-1209. PMID: 39164802
Introduction: Lonoctocog alfa is a single-chain factor VIII (FVIII) molecule with high binding affinity to von-Willebrand-factor. While it is well known that its plasma activity is underestimated by one-stage clotting...
3.
Piibor J, Waldmann A, Prasadani M, Kavak A, Andronowska A, Klein C, et al.
Biomolecules . 2024 Jun; 14(6). PMID: 38927030
Cow uterine infections pose a challenge in dairy farming, resulting in reproductive disorders. Uterine fluid extracellular vesicles (UF-EVs) play a key role in cell-to-cell communication in the uterus, potentially holding...
4.
Wattad N, Ozer E, Altgilbers S, Klein C, Cohen E, Zuckrman O, et al.
Poult Sci . 2024 Jun; 103(8):103890. PMID: 38870613
Generation of transgenic birds can be achieved by temporal suppression of endogenous spermatogenesis in males prior to primordial germ cell implantation. One of many established methods to induce male sterility...
5.
Hamedani N, Donners A, van Luin M, Gasper S, Ruhl H, Klein C, et al.
J Thromb Haemost . 2023 Sep; 21(12):3490-3500. PMID: 37741510
Background: Accurate measurement of emicizumab in the presence of factor (F) VIII is required in patients with severe hemophilia A treated with emicizumab, as well as additional need for FVIII...
6.
Herbicht R, Neufeld G, Klein C, Henning H
Theriogenology . 2023 Jun; 209:50-59. PMID: 37356279
The aim of this study was to validate a novel sperm purification device, the VetCount™ Harvester, for use in bovine in vitro fertilization (IVF). The device's performance was compared to...
7.
Diel de Amorim M, Dong L, Byron M, Foster R, Klein C, Saleh M, et al.
Sci Rep . 2023 Mar; 13(1):4616. PMID: 36944665
Oxytocin is a hormone with functions in: reproduction, maternal bonding, milk ejection, and feeding/social behavior, and is reported to be present in a variety of tissues. Our goal is to...
8.
Pezeshkpoor B, Sereda N, Berkemeier A, Matuschek I, Schwarz N, Turecek P, et al.
J Thromb Haemost . 2023 Mar; 21(6):1503-1514. PMID: 36934798
Background: The standard therapy for patients with hemophilia A (HA) is the replacement with factor VIII (FVIII) therapeutics. To overcome the limitation of short half-life of wild-type FVIII protein, polyethylene...
9.
Santa M, Umhang G, Klein C, Grant D, Ruckstuhl K, Musiani M, et al.
Proc Biol Sci . 2023 Mar; 290(1994):20230128. PMID: 36883278
(), the causative agent of human alveolar echinococcosis (AE), is present in the Holarctic region, and several genetic variants deem to have differential infectivity and pathogenicity. An unprecedented outbreak of...
10.
Diel de Amorim M, Bramer S, Rajamanickam G, Klein C, Card C
Theriogenology . 2022 Dec; 198:47-60. PMID: 36549183
Our objectives were to examine changes in endometrial and luteal gene expression during estrus, diestrus, pregnancy and treatments to induce luteolysis and putatively induce luteostasis. Groups were: Diestrus (DIEST), Estrus...